Slide 1: FY26 Results Presentation
FY26 Results Presentation 19 August 2026
Slide 2: Disclaimer
Disclaimer The information contained in this document (“Document”) has been prepared by Alcidion Group Limited ACN 143 142 any change in expectations in relation to any such statements or any change in events, conditions or circumstances 410 (referred to as “Alcidion” or “Company”). This Document is
Slide 3: Snapshot & Miya Precision Platform
01. Snapshot & Miya Precision Platform
Slide 4: Investment Highlights
Investment Highlights Large Addressable Market Attractive Financial Profile Marquee Customers › Global patient flow market growing at 18% › $51.6M FY26 revenue, up 27% pcp › $50M over 10 years with North Cumbria NHS CAGR and expected to hit US$10B by 2034 to deliver new EPR › ARR as at 30 June 2026
Slide 5: Company Overview
Company Overview A leading global health informatics platform modernising legacy health systems at scale Global health informatics platform enhancing and replacing outdated, manual and legacy systems 100+ 130k+ 1B+ to meet modern day demands in healthcare. Healthcare Clients Observations Active User
Slide 6: Strong Global Footprint
Strong Global Footprint Growing global operations diversified across attractive target markets More than 40 NHS trusts Global footprint across the UK, Australia and NZ. Healthcare Providers 100+ clinical system in every state implementations. Canada Exploring New Markets All 4 regions of A platform
Slide 7: Alcidion: Solving critical healthcare challenges
Alcidion: Solving critical healthcare challenges Hospital Bed icon Core Admin / clinical staff lack Long-term patient medical Disparate systems don’t Hospital executives lack Ability to safely monitor problems real-time visibility on bed history is incomplete, interoperate; challenges real-time visi
Slide 8: What is Miya Precision?
What is Miya Precision? An unrivalled clinicial and administration platform Designed for AI Miya Precision allows for AI enabling data consolidation to deliver insights to clinicians, whilst maintaining patient safety Digital Clinical Workflow Operate in Real-Time Miya Precision enables clinicians S
Slide 9: FY26 Highlights
02. FY26 Highlights EXECUTIVE SUMMARY
Slide 10: FY26 – Financial Highlights
FY26 – Financial Highlights Growth across all key financial metrics Revenue ARR2 (as at 30 Jun-26) New & renewal TCV EBITDA3 Positive operating cashflow $51.6M $38.3M $78.5M $6.2M $6.8M Up 27% on pcp 1 Up 34% on pcp Up 6% on pcp Up 28% on pcp Up 19% on pcp Driven by several contract Incl. ARR of $3.
Slide 11: FY26 – Operational Highlights
FY26 – Operational Highlights Continuing sales momentum + strategic patient flow acquisition › Significant new and expanded contracts: › Sept-25: North Cumbria NHS Trust2 (UK): Expanded partnership with Mizaic (EDM1 solution) and non-clinical comms (in Q3) › Nov-25: Leidos Australia (AUS): Expansion
Slide 12: Financial Results
03. Financial Results FY26 RESULTS
Slide 13: Profit & Loss
Profit & Loss Strong revenue growth driving improved operating leverage Profit & loss (A$000) FY25 FY26 % Change › 27% increase in revenue Recurring revenue: › 21% increase in recurring revenue driven by full year impact of new Product - M&S1 + annual licences 25,968 31,885 23% customer wins in FY25
Slide 14: Revenue Dashboard
Revenue Dashboard Sustainable growth underpinned by long-term, contracted and high-quality recurring revenue 51.6 26.1 47% 49% 49% 63% 63% H1 vs H2 40.4 37.1 40.8 Geographical Revenue 34.4 21.4 23.1 Split (%) 18.0 25.5 Split ($M) 21.5 53% 51% 51% 25.5 37% 37% 19.0 19.1 17.6 12.9 FY22 FY23 FY24 FY25
Slide 15: Our revenue model
Our revenue model Sustainable growth underpinned by long-term, contracted and high-quality recurring revenue Core Product Platform Solutions Patient Flow Virtual Care Integrated Care Record Modern Modular EPR Operations Centre Clinical Workflow Specialised Care Revenue Capital License Annual subscri
Slide 16: Balance Sheet
Balance Sheet Significant balance sheet flexibility to pursue growth opportunities Balance sheet ($000) 30 Jun 25 30 Jun 26 Cash & cash equivalents 17,697 20,642 › $20.6M cash and no debt as of 30 June 2026 Trade & other receivables 3,680 6,060 › Up $2.9M vs FY25 (incl. $1.5M net acquisition payment
Slide 17: Cashflow
Cashflow High EBITDA to cashflow conversion Cash flow ($000) FY25 FY26 % Change › Positive operating cashflow of $6.8M, up 19% on pcp Receipts from customers 50,858 56,060 10% › Net consideration payment for Kyra flow acquisition of $1.5M Payments to supplier and employees (45,162) (49,317) 9% Net I
Slide 18: Accelerating customer wins
04. Accelerating customer wins
Slide 19: Sales momentum accelerating…
Sales momentum accelerating… $140m+ of new and renewal TCV won over past 24 months Average contract term 5-10 years Q3 FY26 Jul 2024 Nov 2024 Feb 2025 Sept 2025 Q2 FY26 Mar 2026 Hywel Dda & South Hume Rural Health NALHN Hywel Dda North Cumbria NHS Lanarkshire NHS Gold Coast Health Tees New customer
Slide 20: Notable FY26 New / Expansion Wins
Notable FY26 New / Expansion Wins Continued ability to expand functionality with customers over time leading to TCV uplift Leidos Australia / ADF (AUS) North Cumbria NHS Trust (UK) › 3rd expansion to the original contract to June 2028, › Expanded to include third-party partner, Mizaic with extension
Slide 21: Land and Expand Strategy Driving TCV Uplift
Land and Expand Strategy Driving TCV Uplift Delivering tangible examples of strategy execution… 1 2 3 4 Leidos Australia (Aus) North Cumbria (UK) South Tees (UK) Hume (Aus) › Q2’22 – 6-year contract to deliver › Q3’25 – 10-year contract for EPR › Q2’20 – 5-year contract for several › Q1’25 – New con
Slide 22: Further EPR Validation: UH Sussex
Further EPR Validation: UH Sussex In May 2026, signed contract with University Hospitals Sussex for new EPR platform solution Contract Terms EPR Contract - Overview › Selected following a competitive tender process › Deploy Miya Precision core modules and Better medications management - provides cli
Slide 23: Successful Deployments in FY26
Successful Deployments in FY26 Product Implementation delivery has always been a strength for Alcidion University Hospitals Southampton (UK) North Adelaide Local Health Network (AUS) › Deployed Miya Emergency – second customer to › In Q1, ‘live’ with Miya Flow, Access and Command deploy module and f
Slide 24: Expanding ALC position in patient flow market
05. Expanding ALC position in patient flow market
Slide 25: Patient Flow Market
Patient Flow Market 18% CAGR growth with structural tailwinds across Alcidion’s core markets Overview GLOBAL MARKET SIZE (US$M) 10,386 › Global patient flow market growing at 18.1% CAGR to a forecast US$10.4bn by 2034 7,447 5,321 › UK growing at 18.6% CAGR to US$588m by 2034 3,814 › Australia growin
Slide 26: Acquisition of Kyra Flow products…
Acquisition of Kyra Flow products… Consolidating Alcidion’s leadership position in patient flow market across ANZ Highly complementary to Alcidion core business Consolidates market position in ANZ market Builds recurring revenue whilst being earnings accretive Future opportunities for Miya Precision
Slide 27: Strategic Rationale
Strategic Rationale Customer Patient Flow Long-standing Attractive Expansion Leader Customer Base Financial Profile • 33 customers across 5 of 6 • Expands leading position in • Average Top 10 customer • FY26F revenue of ~$3.6M states ANZ & UK flow market relationship is ~10 years • 90%+ recurring re
Slide 28: Growth Strategy and Outlook
06. Growth Strategy and Outlook
Slide 29: Growth Pillars Support a Global Platform
Growth Pillars Support a Global Platform Multi-focus approach combining growth within existing customers, expansion in existing territories and attractive new markets and geographies Organic Growth 1 Scale Existing Markets 2 Evolve Product Functionality 3 Expand into New Geographies & Adjacencies •
Slide 30: Outlook & Guidance
Outlook & Guidance Growing ARR and contracted implementation underpins EBITDA positive starting position Outlook FY27 Guidance • As of 30 June 2026, contracted & renewal revenue expected to • Growth to continue in FY27 with Revenue and Underlying be recognised in FY27 of $44.9M, up 32% on prior year
Slide 31: Appendix
07. Appendix
Slide 32: Miya Precision: An Orchestration layer &/or System of Record
Miya Precision: An Orchestration layer &/or System of Record As AI agents are able to execute work autonomously, the SaaS layer is compressed with value shifting to the orchestration and trusted systems of record Historically Future The traditional ‘SaaS’ model The ‘SaaS’ layer has been compressed U
Slide 33: Miya Precision as the System of Record
Miya Precision as the System of Record • AI enablement doctor Icon 1194893 Scenario 1 Scenario 2 • Results Management • Task Management • Longitudinal Patient Record System of • Patient Flow Management Engagement • Virtual Care • Predictive Analytics electronic health record icon database icon • Cli
Slide 34: @ ALCIDION
A @ ALCIDION